Safeguard Scientifics

Type

Venture Capital

Status

Active

Location

Radnor, United States

Total investments

129

Average round size

15M

Portfolio companies

84

Rounds per year

1.82

Lead investments

47

Follow on index

0.35

Exits

36

Stages of investment
Private EquityEarly Stage VentureLate Stage Venture
Areas of investment
BiotechnologyE-CommerceInternetSoftwareAnalyticsInformation TechnologyHealth CareSaaSMedical DeviceMedical

Summary

In 1953 was created Safeguard Scientifics, which is appeared as Corporate Investor. The fund was located in North America if to be more exact in United States. The main office of represented Corporate Investor is situated in the Radnor.

The current fund was established by Warren Musser. The overall number of key employees were 7.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Safeguard Scientifics, startups are often financed by Social Capital, BioAdvance, MentorTech Ventures. The meaningful sponsors for the fund in investment in the same round are Novitas Capital, Social Capital, BioAdvance. In the next rounds fund is usually obtained by Core Capital Partners, UOB Venture, Social Capital.

Among the most popular portfolio startups of the fund, we may highlight MediaMath, E-Duction, Apprenda. Among the most successful fund investment fields, there are Medical Device, Health Care. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has specific favorite in a number of founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund.

The fund is constantly included in 2-6 investment rounds annually. The top amount of exits for fund were in 2010. Comparing to the other companies, this Safeguard Scientifics performs on 7 percentage points less the average number of lead investments. Considering the real fund results, this Corporate Investor is 35 percentage points more often commits exit comparing to other organizations. The high activity for fund was in 2000. Despite it in 2019 the fund had an activity. When the investment is from Safeguard Scientifics the average startup value is 100-500 millions dollars. The common things for fund are deals in the range of 10 - 50 millions dollars.

Show more

Investor highlights

Industry focus
HealthcareFintechMedia/ContentCybersecurityAI/Big Data Show 1 more
Stage focus
SeedSeries ASeries B
Check size
5M — 25M

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Investments analytics

Analytics

Total investments
129
Lead investments
47
Exits
36
Rounds per year
1.82
Follow on index
0.35
Investments by industry
  • Health Care (52)
  • Software (30)
  • Medical (26)
  • Biotechnology (21)
  • SaaS (21)
  • Show 108 more
Investments by region
  • United States (128)
  • Canada (1)
Peak activity year
2000

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
17
Avg. valuation at time of investment
42M
Group Appearance index
0.82
Avg. company exit year
9
Avg. multiplicator
2.34
Strategy success index
0.50

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Moxe Health 01 Jun 2022 Health Care, Hospital, Wellness, Medical Early Stage Venture 30M United States, Wisconsin, Madison
Prognos Health 17 Jun 2013 Software, Analytics, Health Care, Health Diagnostics, Life Science Early Stage Venture 15M United States, New York, New York

Similar funds

By same location

By same geo focus

By doing lead investments

How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.